Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
about
G Protein-Coupled Receptor Signaling in Stem Cells and CancerChallenges in the clinical utility of the serum test for HER2 ECDInsights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's diseaseInvolvement of TACE/ADAM17 and ADAM10 in etoposide-induced apoptosis of germ cells in rat spermatogenesisHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?A functional role for ADAM10 in human immunodeficiency virus type-1 replicationInterference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.Functional protease profiling for diagnosis of malignant disease.ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.Targeted treatment of advanced and metastaticbreast cancer with lapatinib.Targeting the function of the HER2 oncogene in human cancer therapeutics.The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinomaMonitoring serum HER2 levels in breast cancer patients.Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cellsRelationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancerSheddomeDB: the ectodomain shedding database for membrane-bound shed markers.Antibodies binding the ADAM10 substrate recognition domain inhibit Eph functionTwo distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5Molecular analysis of neural crest migrationEGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinoma.Role of trastuzumab in the management of HER2-positive metastatic breast cancer.Potential of ErbB4 antibodies for cancer therapy.Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.Evaluation of HER2 in breast cancer: reality and expectations.The Mysterious Ways of ErbB2/HER2 TraffickingThe human β-amyloid precursor protein: biomolecular and epigenetic aspects.MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function.Perspectives of HER2-targeting in gastric and esophageal cancer.Role of MicroRNA-103a Targeting ADAM10 in Abdominal Aortic Aneurysm.Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array.
P2860
Q26853233-F38AB2B9-6D57-45EF-8CF4-FEF57FCEA5FBQ26861754-F4C14E86-A409-48A8-84C0-BC64FF0797A6Q26999922-AAAA2766-E40F-458A-81ED-5A45D2154ED8Q28580958-3426BA69-ABB4-4BDB-B1D4-1633E1CFB966Q33737278-381D6DED-E991-4CB9-AB2A-F1A2A74C04EEQ33807091-21F8AEBF-677F-4A04-BF99-6235BD08B960Q33898509-4D05F566-52BB-49B3-969E-6C5ADA932DD6Q33966430-322C6171-4162-4601-824F-B2A2109321F1Q34116114-969DAE6C-A106-4859-ABDD-EB235C80C629Q34334333-1C0050C7-A421-447D-9929-EF8F1831FDC0Q34363419-6E8BF900-D8FA-4BB4-A067-D0BA4FF9E403Q34766486-76FEBF85-B0D9-4A7F-90E7-87C2C52D401DQ35036351-9D9EAFF7-1522-42A3-A094-034F856141D0Q35505245-372B021C-5D40-425B-9432-4EC32580A1FDQ35686002-5283140E-003B-4528-8417-8B2C32E4049FQ35781480-6AE246CD-5743-42B4-B626-8CC4BF8C92C1Q35854297-ACC64745-FDB1-40B7-9873-ABB3F5E8ADB0Q36329547-0C99ED7F-198E-4097-BD4B-0EB0F66512FBQ36648232-2AE7C3AC-7DC3-4DCC-9F08-650BF3370016Q36666328-D05C6BF5-9732-4CD9-B7D0-C7EBDB2E212AQ36715904-76DB4C8D-6DB2-4661-B6D8-F99141743331Q36773013-D2F8860B-3219-4115-8490-7BF34F1D216BQ36848016-424ABC01-12D0-4257-B8FB-C4A319ABE61AQ37058221-6993F848-B1B4-424E-AEE5-54A217AFB66CQ37206247-7D4D524E-997A-4234-A707-3375C7333549Q37233360-864BBDE8-C27E-42D6-884A-5DD763631CEFQ37285551-EBE14558-186E-4332-8097-562D5CCEA518Q37355370-6E6802A9-3177-4E9C-BD13-C7952966F6D6Q37658764-774BDDAD-5395-4092-9BE0-FD0CA5F7BFF7Q37666730-98C64F61-AB11-48B3-880A-46A2FF787177Q38068491-81811435-6A74-45F0-9260-E8FEB6785702Q38089837-7A614629-92CF-4C94-A52F-5DF7A77EC647Q38237727-8DC33012-CAD4-4CDC-B0D7-EA627C2A7CA6Q38365416-FC223AA0-43C1-4423-96D7-D1C2BE87E8A3Q38444096-C123A2C5-B69C-458E-8037-ABEE758A3DA3Q38673589-628538B5-7440-497E-9DFF-586A20F67C38Q38696638-086C04BF-5BD4-4266-90BF-808833C9E4D9Q38848389-163278BE-9611-4E2F-868C-EDA70BDA1C62Q38867927-2CD83275-A9CB-43E1-B877-8AF9888D3CB3Q38923909-5A5F33EF-6EB4-45F6-A7B1-1EA37267771E
P2860
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of ADAM10 as a ...... expressing breast cancer cells
@ast
Identification of ADAM10 as a ...... expressing breast cancer cells
@en
Identification of ADAM10 as a ...... expressing breast cancer cells
@nl
type
label
Identification of ADAM10 as a ...... expressing breast cancer cells
@ast
Identification of ADAM10 as a ...... expressing breast cancer cells
@en
Identification of ADAM10 as a ...... expressing breast cancer cells
@nl
prefLabel
Identification of ADAM10 as a ...... expressing breast cancer cells
@ast
Identification of ADAM10 as a ...... expressing breast cancer cells
@en
Identification of ADAM10 as a ...... expressing breast cancer cells
@nl
P2093
P3181
P356
P1476
Identification of ADAM10 as a ...... expressing breast cancer cells
@en
P2093
Brian Metcalf
Chunhong He
Cindy Marando
Colin Zhang
Costas Agrios
David Burns
Dawn Ellis
Ding-Quan Qian
Gengjie Yang
P304
P3181
P356
10.4161/CBT.5.6.2708
P407
P577
2006-06-01T00:00:00Z